Takashige Abe

25PUBLICATIONS
71CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSimulation, modelling, and programming of mechatronics systemsMedicine, nursing and health curriculum and pedagogyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Mar 17, 2026
A Minimum 3-Year Follow-Up of Nivolumab-Plus-Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J-ENCORE Study.

Shuzo Hamamoto, Masahiro Nozawa, Suguru Shirotake

|Mar 11, 2026
Current Treatment Patterns and Outcomes of Sex Cord Stromal Tumor Patients in Japan.

Takashige Abe, Kosuke Miyai, Toyonori Tsuzuki

|Nov 26, 2025
Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE Study.

Tomokazu Sazuka, Katsunori Tatsugami, Suguru Shirotake

|Apr 24, 2025
The Effectiveness and Safety Profile of Nivolumab-Plus-Ipilimumab in Previously Untreated Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma (J-ENCORE Study).

Koshiro Nishimoto, Go Kimura, Tomokazu Sazuka

Pageof 5